ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07638
-0,08%
Bitcoin
64.142,51
0,39%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. vTv Therapeutics Inc (VTVT)

  7. vTv Therapeutics Inc (VTVT) News

VTVT

vTv Therapeutics (VTVT)

vTv Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:VTVT
DatumZeitQuelleÜberschriftSymbolFirma
19/03/202413h30PR Newswire (US)CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMITNASDAQ:VTVTvTv Therapeutics Inc
13/03/202413h00GlobeNewswire Inc.vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate UpdateNASDAQ:VTVTvTv Therapeutics Inc
07/03/202422h47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTVTvTv Therapeutics Inc
07/03/202420h34Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VTVTvTv Therapeutics Inc
06/03/202401h52Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:VTVTvTv Therapeutics Inc
05/03/202414h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
04/03/202414h00GlobeNewswire Inc.vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 DiabetesNASDAQ:VTVTvTv Therapeutics Inc
01/03/202414h00GlobeNewswire Inc.vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:VTVTvTv Therapeutics Inc
01/03/202401h34Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTVTvTv Therapeutics Inc
28/02/202415h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
28/02/202415h14Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VTVTvTv Therapeutics Inc
28/02/202414h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
28/02/202414h00GlobeNewswire Inc.vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D FundNASDAQ:VTVTvTv Therapeutics Inc
22/02/202422h00PR Newswire (US)CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCENASDAQ:VTVTvTv Therapeutics Inc
22/12/202322h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
19/12/202322h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
12/12/202322h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
20/11/202322h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
15/11/202314h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
15/11/202314h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
09/11/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTVTvTv Therapeutics Inc
09/11/202322h30GlobeNewswire Inc.vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:VTVTvTv Therapeutics Inc
09/11/202322h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
08/11/202314h00GlobeNewswire Inc.vTv Therapeutics to Participate at the Stifel 2023 Healthcare ConferenceNASDAQ:VTVTvTv Therapeutics Inc
02/11/202313h00GlobeNewswire Inc.vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical OfficerNASDAQ:VTVTvTv Therapeutics Inc
01/11/202313h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
01/11/202313h00GlobeNewswire Inc.vTv Therapeutics Announces Sale of Shares in Reneo Pharmaceuticals for Proceeds of $4.4 MillionNASDAQ:VTVTvTv Therapeutics Inc
27/09/202314h30PR Newswire (US)CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19NASDAQ:VTVTvTv Therapeutics Inc
26/09/202314h30PR Newswire (US)Cantex and Allegheny Health Network Announce Initiation of a Phase 1/2 Study of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic CancerNASDAQ:VTVTvTv Therapeutics Inc
25/09/202322h20Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:VTVTvTv Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VTVT

Kürzlich von Ihnen besucht

TG
LHA
Deutsche Lufthansa
NYSE
KO
Coca Cola
NYSE
NKE
Nike
NYSE
MRK
Merck
CCOM
US30
US 30
TG
ALV
Allianz
NYSE
DIS
Walt Disney
TG
DTE
Deutsche Telekom
AMEX
XLV
Health Care Select Sector
DBI
DAX
DAX
TG
432
Arbor Metals
CCOM
SILVER
SILVER
NASDAQ
QQQ
Invesco QQQ Trust Series 1
DBI
SDXP
SDAX
TG
CBK
Commerzbank
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten